A technological chain for the development of antibacterial lysins against fermentation contaminants and infectious diseases Ghent University
Lysins are a broad class of bacteriophage-encoded, enzyme-based antibacterials with a new mode-of-action based on active peptidoglycan degradation. While initially considered for human healthcare only, the potential market of lysins has now been expanded to each sector where bacteria are undesired, including the fermentation industry that suffers significant yield and profit losses from recurrent bacterial contaminations. To leverage the ...